Big pharma meets big tech! Novartis CEO Vas Narasimhan just joined the Anthropic board, signaling a massive leap for AI-driven medicine.

Accelerating Discovery: AI will now supercharge drug development timelines. Clinical Precision: Expect smarter diagnostics and personalized patient care.

Market Surge: The AI healthcare sector is skyrocketing toward a $180 billion valuation. The future of healing is algorithmic.